ABSTRACT: Cardiovascular disease (CVD) remains the leading cause of mortality for women, and only a small percentage of women have optimally managed risk factors. One of the strongest risk factors for CVD is an increased lipid level. Many women seek primary care from obstetrician–gynecologists who often identify and provide initial management of dyslipidemia in these women. Thus, it is imperative that obstetrician–gynecologists become familiar with the identification and treatment of women with dyslipidemia to minimize their future risk of CVD. This monograph provides a brief primer on the epidemiology, pathophysiology, diagnosis, and management of dyslipidemia in women, as it pertains to CVD risk.
- Jump to
- Search page
-
Resources
Resources Close
Nonmembers: Subscribe now to access exclusive ACOG Clinical content, including:
ACOG Clinical is designed for easy and convenient access to the latest clinical guidance for patient care. Developed with members’, physicians’, and women’s health care professionals’ needs in mind, user-friendly features include:
- Easy, advanced search function to find the most relevant guidance
- Enhanced document presentation
- Advanced features and functionality
You’ll find clinical content written and peer reviewed by experts and valuable information that spans guidance on the diagnosis and management of the full spectrum of obstetric and gynecological conditions and clinical management issues.
Note for Life Fellows: Annual membership dues are waived but there is a discounted annual subscription fee of $95 for access to publications such as the Green Journal, Practice Bulletins, and Committee Opinions. Individual subscriptions include print and online access. Subscribe today.
Subscribe
![Figure 4. Algorithm for identification and management of statin benefit groups. This is a general decision algorithm for patients who may benefit from statin treatment. The algorithm is based on the American College of Cardiology/American Heart Association’s guidelines, which specifically identify patients with diabetes mellitus aged 40–75 years with a low-density lipoprotein cholesterol level of 70–189 mg/dL (a previous step in the algorithm that is not shown in this figure identifies patients with a low-density lipoprotein cholesterol level greater than 190 mg/dL). Abbreviation: CVD, cardiovascular disease. (Data from Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. American College of Cardiology/American Heart Association Task Force on Practice Guidelines [published errata appear in J Am Coll Cardiol 2015;66:2812; J Am Coll Cardiol 2014;63:3024]. J Am Coll Cardiol 2014;63:2889–934 .)](/-/media/project/acog/acogorg/clinical/images/clinical-updates/2019/03/evaluationandmanagementoflipiddisorders/cu088-20190300-fig4.png)
